NovoCure LimitedEquity-NMS: NVCR
Equity-NMS: NVCR
$16.25
+0.94
(3 Mar)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$16.25
Open
$16.25
Today’s high
$16.31
Today’s low
$15.19
52W low
$10.87
52W high
$83.6
1Y
-79.21%
5Y
-21.93%
PE
-7.92
EPS (TTM)
-1.95
Shares O/S
107.09M
Market cap
1.74B
Insights
NVCR is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About NovoCure Limited

NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and pleural mesothelioma.

It is conducting pivotal studies evaluating the use of TTFields in the treatment of ovarian cancer, brain metastases from non-small cell lung cancer (NSCLC) (brain metastases) and pancreatic cancer. Its key priorities are to drive commercial adoption of Optune, its commercial TTFields device. It also has a license to market Optune in China, Hong Kong, Macau and Taiwan. It has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer. .


FAQs

Can I buy NovoCure Limited shares in India?
How to buy NovoCure Limited shares in India?
What is the share price of NovoCure Limited?
What is the Market Capitalization of NovoCure Limited?
What is the PE ratio of NovoCure Limited?
Is NovoCure Limited a good stock to buy?
In which sector / industry does NovoCure Limited operate?